Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drug Science is a UK-based independent charity and research organization focused on evidence-based drug education, harm reduction, medical cannabis, and psychedelic science. Founded by Professor David Nutt, it was established to provide scientific analysis of drug harms and benefits free from political or commercial influence. The organization publishes research, runs education and training programs, supports healthcare professional training, and engages policymakers and the public on drug policy and prescribing issues. Its current activities prominently include medical cannabis access, psychedelic medicine education, and public-facing drug information resources. Drug Science is not a therapeutic product developer in the conventional biotech or pharma sense, but it operates at the intersection of healthcare, clinical education, and drug policy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drug Science.